As every corner of the world sees COVID-19 impact their communities, research and science is more important than ever. The worldwide research community, including Cayuse customers, are rising to the enormous challenge and we are so thankful for their passionate and dedicated work.

To honor the work of COVID-19 researchers around the globe, we’ve compiled just a few of the many stories highlighting the impressive research of our customers.


UNC-Chapel Hill scientists hopeful new antiviral drug can treat COVID-19

In collaboration with Vanderbilt and Emory universities, scientists at UNC-Chapel Hill are helping develop a drug that has shown to reduce lung damage in mice infected with viruses related to COVID-19.


University of Pittsburgh team makes progress on possible vaccine

Work by a Pitt researcher looking into the SARS coronavirus nearly 20 years ago, and the MERS coronavirus six years ago, has led to a potential COVID-19 vaccine that has shown early promise in tests. The University of Pittsburgh is also collaborating with the Pasteur Institute in Paris and the Austrian drug company Themis Bioscience with funding from the Coalition for Epidemic Preparedness Innovation, a Norway-based organization financed by the Bill and Melinda Gates Foundation.


Wistar Institute among facilities working to find vaccine 

Among the facilities working on a COVID-19 vaccine, is the Wistar Institute in Philadelphia. They have a DNA footprint of the virus that will be used in a potential vaccine. The Wistar Institute worked on a vaccine for Ebola after an outbreak of that virus in 2014.


University of Oklahoma to participate in COVID-19 clinical trial

UO Medicine has been approved to participate in a new clinical trial of a promising therapy for the hardest hit COVID-19 patients. The trial, called “Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19,” is a collaboration with the Mayo Clinic and involves taking plasma from a recovered COVID-19 patient and giving it to a current patient.


Texas A&M working on drugs to treat COVID-19

Texas A&M University’s Wenshe Ray Liu and his research team have focused their lab solely on searching for drugs to treat COVID-19. The researchers were the first to identify the antiviral drug remdesivir as a potential COVID-19 treatment in a research study published in January. The researchers are working to develop drugs that can prevent the virus that causes COVID-19 and other coronaviruses from replicating once inside human cells.


University of Nebraska Medical Center search for a proven COVID-19 treatment

UNMC and professor and infectious diseases physician, Dr. Andre Kalil are leading the UNMC arm of a national trial of an experimental antiviral drug called remdesivir. So far about 100 patients, all with more serious cases of COVID-19 affecting the lungs, have been enrolled nationwide. The trial, which kicked off at UNMC, is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health and calls for enrolling nearly 400 patients in the trial at 50 sites worldwide.


We’re so thankful for the research community and feel honored to serve institutions like these and more. We have you, your families, and your communities in our thoughts, and our hearts go out to our affected customers and their loved ones. If your institution is working on COVID-19 research, we’d love to hear about it.

Learn more about our annual conference, Connect by Cayuse, and join us virtually for free in September 2020!